Skip to main content
. 2011 Feb 14;3(2):89–95. doi: 10.4168/aair.2011.3.2.89

Fig. 8.

Fig. 8

Intracellular cell adhesion molecule (ICAM)-1 concentration before (V1) and during therapy (V4), and at 3 (V5) and 6 months (V6) after the last IVIg injection. The ICAM-1 concentration was significantly lower at the 3-month follow-up visit (V5) compared with the concentration at V1, but it had increased by the 6-month follow-up visit (V6).